Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$12.92 USD
-0.23 (-1.75%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $12.90 -0.02 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -1.26 |
EPS Last Quarter | -1.58 |
Last EPS Surprise | -33.90% |
ABR | 2.71 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.90 |
Next Year | -4.55 |
EPS (TTM) | -6.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.47M | 16.89M | 67.01M | 77.82M |
# of Estimates | 5 | 5 | 4 | 5 |
High Estimate | 18.00M | 20.00M | 72.60M | 111.94M |
Low Estimate | 14.46M | 13.73M | 59.24M | 49.81M |
Year ago Sales | 17.80M | 18.89M | 79.20M | 67.01M |
Year over Year Growth Est. | -7.47% | -10.59% | -15.40% | 16.13% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.26 | -1.20 | -4.90 | -4.55 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -1.15 | -0.91 | -4.35 | -6.89 |
High Estimate | -1.11 | -0.91 | -4.35 | -3.35 |
Low Estimate | -1.51 | -1.46 | -5.40 | -6.89 |
Year ago EPS | -1.79 | -1.86 | -6.38 | -4.90 |
Year over Year Growth Est. | 29.61% | 35.48% | 23.20% | 7.18% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -1.26 | -1.20 | -4.90 | -4.55 |
7 Days Ago | -1.26 | -1.20 | -4.90 | -4.55 |
30 Days Ago | -1.26 | -1.20 | -4.90 | -4.55 |
60 Days Ago | -1.26 | -1.20 | -4.90 | -4.55 |
90 Days Ago | -1.16 | -0.99 | -4.44 | -4.37 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.26 | -1.20 | -4.90 | -4.55 |
Zacks Consensus Estimate | -1.26 | -1.20 | -4.90 | -4.55 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.58 | -1.33 | -1.86 | -1.79 | NA |
Estimate | -1.18 | -2.11 | -2.38 | -1.91 | NA |
Difference | -0.40 | 0.78 | 0.52 | 0.12 | 0.26 |
Surprise | -33.90% | 36.97% | 21.85% | 6.28% | 7.80% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more